Pain. Xxxx X. Xxxxxxxx (with respect to environmental matters) Xxxxx X. Xxxxxxxx (with respect to intellectual property matters) Xxxxxx X. Xxxx Xxxx X. Xxxxxx Xxxxxxxx X. Xxxxxxxxxx Purchaser’s knowledge Xxxxxxx Xxxxxx Xxxxx Xxxxxx Xxxx Xxxxxx Xxxxx Xxxxxxx
Pain. 14. She states that she suffers from significant and frequent pain from a number of sources which is intense and sometimes almost unbearable.
Pain. Discomfort associated with DC injections is normal and usually of a short duration. It is possible to have a fainting episode (vasovagal) from discomfort or anxiety about the injections. Procedural discomfort is managed with oral pain medicine, local anesthesia injections before DC is injected, and over the counter analgesics. Complications (adverse events) Potential complications attributable to the injection of DC for fat reduction in the chin and jawline are: Damage to Marginal Mandibular Nerve - DC injections in the area of the marginal mandibular nerve, which is located in the vicinity of the jaw bone can occur. This would produce diminished motion in the corner of the mouth. According to data from the research on DC, this is a rare complication and generally resolves over time. Difficulty to swallow - Difficulty to swallow has been reported in a few patients that have undergone DC injections. Typically, this resolves. Individuals who have a history of swallowing difficulties may not be suitable for DC injections. Infection - Although infection following injection of DC is unusual, bacterial, fungal, and viral infections can occur. Should any type of skin infection occur, additional treatment including antibiotics may be necessary. Damage to deeper structures - Deeper structures such as nerves, salivary glands, and the neck muscles may be damaged during the course of injection. Injury to deeper structures may be temporary or permanent. Temporary numbness can occur in the area where DC is injected. Skin Necrosis - It is very unusual to experience death of skin and deeper soft tissues after DC injections. Skin necrosis can produce unacceptable scarring. Should this rare complication occur, additional treatments, or surgery may be necessary. Granulomas and Fat Necrosis - Painful masses in the skin and deeper tissues after a DC injection are extremely rare. Should these occur, additional treatments including antibiotics or surgery may be necessary. These may produce scarring within the skin and deeper structures. Allergic Reactions and Hypersensitivity - As with all injectable products, allergic reactions may occur. Allergic reactions may require additional treatment. It is unknown if DC is associated with serious systemic anaphylactic allergic reactions. Accidental Intra-arterial injection - One of the risks with using this product is unintentional injection into a blood vessel. The chances of this happening are very small and may not be of consequence, ...
Pain a sensation of hurting or strong discomfort in some part of the body caused by an injury, illness, disease, function- al disorder or condition. Pain includes low back Pain, post- operative Pain and post-operative dental Pain. Participating Provider – a Participating chiropractor, Partic- ipating acupuncturist or other licensed health care provider under contract with ASH Plans to provide Covered Services to Members. Notes Notes
Pain. Author manuscript; available in PMC 2016 December 01. Author Manuscript Published in final edited form as:
Pain. Pain that interferes with swallowing, eating, or other normal activities requires expeditious (i.e., within 24 hours) treatment by a dentist, physician, or appropriately trained MLP. As with dentoalveolar infections, the inmate may be triaged and stabilized by MLPs or physicians and seen by the dentist at dental sick call. The system must be designed to allow for inmates to be seen within 24 hours for stabilization of their pain and an evaluation of its source. Pain associated with denture irritation can be stabilized by leaving the denture out until the inmate may be seen by a dentist. Level Two Level two is primarily associated with the dental daily sick call or other requests for urgent care. Inmates with intermittent or constant pain, an inability to eat, and other dental symptoms that cause discomfort should have access to assessment and the initiation of treatment within 24 hours by a dentist, physician, or appropriately trained MLP. Examples of Level 2 care are toothaches, infections, and pain of apparent maxillofacial origin. Level Three Level 3 is disease control or routine care. The acute problems have been stabilized in Levels 1 and 2. Inmates who enter this level require a comprehensive treatment plan. When an inmate progresses to Level 3, he should be free from infection; and pain that interferes with normal daily activities. Dental Caries Carious lesions progress slowly and an early lesion takes several years to progress through the enamel of a permanent tooth.
Pain. Analgesia should be prescribed and administered on a REGULAR basis 24 hours a day. If a step by step approach is used there will be fewer side effects.
Pain. Excessive pain may develop following the surgical procedure. The pain may be temporary or chronic, requiring a physician who specializes in pain management to treat you.
Pain. In figure 3a and b box-and-whisker plots of the pain scores as reported by the volunteers are shown. The pain scores of all treatments are similar and very low. No significant differences in pain caused by microneedles of different length or shape were found. The median value of all microneedle arrays was 1, except for the 550A were the median was 2. This array also had the highest maximum pain score of 6. Even though the scores after microneedle treatment and control did not differ significantly, the latter did have the smallest interquartile range.
Pain. Pain remains the major concern for most patients with RA. Its persistence is an important negative consequence of disease. Although controlling pain is one indication of successful treatment, the majority of RA patients have significant amounts of pain despite therapy. Patients consistently rate pain as their most important symptom. [Xxxxxxx et al. 2002] Other than drug studies looking at the effect of reducing inflammation, there are few studies which have specifically looked at pain pathways and the cause of chronic pain in RA patients. [Xxx 2013] Despite pain being a dominant symptom in RA it is not routinely measured and is not part of commonly used composite measures that assess RA such as the DAS28. The most common way of measuring pain is the double anchored 100mm visual analogue scale (VAS), labelled ’No pain at all’ at one end, and ’Pain as bad as it could be’ at the other end. The VAS was first developed in rheumatology in 1974 by Huskisson et al and takes only a few seconds to complete. The pain VAS is part of the American College Rheumatology (ACR) and EULAR/OMERACT core data set [Xxxxxx et al. 1993; xxx Xxxxxx et al. 1996]. The verbal rating scale (VRS) is another simple measure which has been shown to correlate strongly with the VAS [Xxxxxxx et al. 1992] The VRS consists of words which describe the severity of pain – such as ‘none’, ‘mild’, ‘moderate’, ‘severe’ and ‘extreme’. This is not as widely used as the VAS although one study has shown that certain patients may prefer this to the VAS [Xxxxx et al. 2003]. There are other more detailed pain questionnaires available which have been used in clinical studies and add much to the understanding of pain in RA. Their place in routine clinical practice is limited by the amount of time needed to complete the questionnaires. The XxXxxx pain questionnaire [Xxxxxxx 1983] has 102 words in 20 categories and patients are asked to circle words that describe their current pain. The complete XxXxxx pain questionnaire also has a diagram so that patients can indicate the location of their pain. There are also questions relating to the intensity of pain and how it changes with time. Although this questionnaire provides detailed knowledge and insight into the pain experienced in RA it takes at least 15-20 minutes to complete. Even the short version of the questionnaire [Xxxxxxx 1987] is too long to use in routine clinical practice but is useful in the research setting. The rheumatoid arthritis pain scale (RAPS)...
